课题基金 / 基金详情

Second generation genetically encoded photosensitizers and killers for systems neuroscience

Second generation genetically encoded photosensitizers and killers for systems neuroscience
用于系统神经科学的第二代基因编码光敏剂和杀手
批准号:
425957673
负责人:
Privatdozent Dr. Oliver Griesbeck
金额:
$0.0万
依托单位国家:
德国
项目类别:
Priority Programmes
财政年份:
2019
资助国家:
德国
项目状态:
已结题
起止时间:
2018-12-31 至 2023-12-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
New developments of optogenetic reagents are constantly transforming neuroscience until today. In the course of this process, tools have been engineered that aim at efficient photo-ablation of cells in vivo. Some of these reagents demonstrated usefulness for certain applications in vivo. However, it appears that optogenetic ablation of cells with the aid of genetically encoded chromophores has not yet become a versatile tool in circuit neuroscience and that the method requires improvement to realize its full potential. We here propose a collaborative effort that aims at engineering highly sensitive second generation optogenetic tools for the reliable photo-ablation of genetically targeted cells in vivo. Building on two families of proteins that produce reactive oxygen species (ROS) upon illumination, the labs of Griesbeck and Reiff propose to join forces for the engineering (Griesbeck) and in vivo application/verification (Reiff) of new ROS-producing proteins with improved properties. Candidates will be quantitatively tested in physiological and behavioral experiments in Drosophila melanogaster in vivo. Thereby, we will focus on experiments on visual processing including the processing of optic flow, the visual control of navigation and neuronal computations underlying color vision. Improved proteins should include powerful features of classical optogenetic reagents like activation with high spatial resolution and cellular specificity, should as work on the subcellular level to probe the roles of spines or synapses within a circuit, and be largely orthogonal to existing optogenetic reporters. Thus, new ROS-generating proteins for light-induced ablation may become highly useful for neuroscience research in genetic model organisms, but also for a number of other applications in biology and biomedicine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
细胞周期蛋白依赖性激酶Cdk1介导卵母细胞第一极体重吸收致三倍体发生的调控机制研究
  • 批准号:
    82371660
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    魏喆
  • 依托单位:
Next Generation Majorana Nanowire Hybrids
二次谐波非线性光学显微成像用于前列腺癌的诊断及药物疗效初探
  • 批准号:
    30470495
  • 项目类别:
    面上项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2004
  • 负责人:
    邓小元
  • 依托单位: